Improving treatment outcomes for patients with multiple myeloma
Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions
['FUNDING_OTHER'] · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · NIH-10915543
This study is looking at new ways to treat multiple myeloma, a tough blood cancer, by trying out exciting therapies like CAR T cells and radioimmunotherapy to help patients feel better and stay in remission longer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE (nih funded) |
| Locations | 1 site (DUARTE, UNITED STATES) |
| Trial ID | NIH-10915543 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the treatment of multiple myeloma, a challenging blood cancer. The team is exploring innovative therapies, including the use of CAR T cells and radioimmunotherapy, to improve patient outcomes and reduce side effects. By combining these approaches, they aim to achieve longer-lasting remissions and better manage the disease. The research also investigates the potential of oncoviruses in conjunction with existing treatments to overcome resistance mechanisms in cancer cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple myeloma who are seeking new treatment options.
Not a fit: Patients with other types of cancers or those who are not diagnosed with multiple myeloma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for multiple myeloma patients.
How similar studies have performed: Previous research has shown promise in using CAR T cells and radioimmunotherapy for cancer treatment, indicating potential success for this novel approach.
Where this research is happening
DUARTE, UNITED STATES
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — DUARTE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CASERTA, ENRICO — BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- Study coordinator: CASERTA, ENRICO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Patient, Cancers, Disease